These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21368891)

  • 41. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p35 Hemizygous Deletion in 5xFAD Mice Increases Aβ Plaque Load in Males but Not in Females.
    Barrett T; Marchalant Y; Park KHJ
    Neuroscience; 2019 Oct; 417():45-56. PubMed ID: 31421203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease.
    Chang KH; de Pablo Y; Lee HP; Lee HG; Smith MA; Shah K
    J Neurochem; 2010 Jun; 113(5):1221-9. PubMed ID: 20345761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.
    Cruz JC; Kim D; Moy LY; Dobbin MM; Sun X; Bronson RT; Tsai LH
    J Neurosci; 2006 Oct; 26(41):10536-41. PubMed ID: 17035538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
    Sundaram JR; Poore CP; Sulaimee NH; Pareek T; Asad AB; Rajkumar R; Cheong WF; Wenk MR; Dawe GS; Chuang KH; Pant HC; Kesavapany S
    J Neurosci; 2013 Jan; 33(1):334-43. PubMed ID: 23283346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.
    Sun KH; Chang KH; Clawson S; Ghosh S; Mirzaei H; Regnier F; Shah K
    J Neurochem; 2011 Sep; 118(5):902-14. PubMed ID: 21668448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
    Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
    Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
    J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
    Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
    Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
    Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
    J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).
    Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB
    Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
    Hsiao YH; Kuo JR; Chen SH; Gean PW
    Neurobiol Dis; 2012 Mar; 45(3):1111-20. PubMed ID: 22227002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cdk5 as a drug target for the treatment of Alzheimer's disease.
    Lau LF; Seymour PA; Sanner MA; Schachter JB
    J Mol Neurosci; 2002 Dec; 19(3):267-73. PubMed ID: 12540052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease.
    Spencer B; Potkar R; Metcalf J; Thrin I; Adame A; Rockenstein E; Masliah E
    J Biol Chem; 2016 Jan; 291(4):1905-1920. PubMed ID: 26620558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.
    Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J
    Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456
    [No Abstract]   [Full Text] [Related]  

  • 58. Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease.
    Sun KH; Lee HG; Smith MA; Shah K
    Mol Biol Cell; 2009 Nov; 20(21):4611-9. PubMed ID: 19776350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease.
    Song WJ; Son MY; Lee HW; Seo H; Kim JH; Chung SH
    PLoS One; 2015; 10(8):e0136950. PubMed ID: 26317805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
    Zeng Q; Zheng M; Zhang T; He G
    Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.